Navigation Links
Regulus to Present at 32nd Annual J.P. Morgan Healthcare Conference
Date:1/7/2014

Ac-conjugated anti-miR targeting microRNA-122, for the treatment of chronic hepatitis C virus infection. Regulus' commitment to innovation and its leadership in the microRNA field have enabled the formation of strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi. In addition, Regulus has formed a research collaboration with Biogen Idec around its emerging microRNA biomarkers platform.

For more information, please visit http://www.regulusrx.com

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. These and other risks concerning Regulus' programs are described
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regulus to Present at 12th Annual Needham Healthcare Conference
2. Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. Regulus Files Registration Statement for Proposed Initial Public Offering
5. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
6. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 16TH ANNUAL NEEDHAM GROWTH CONFERENCE
8. Scioderm to Present at 32nd Annual J.P. Morgan Healthcare Conference
9. GlySure CEO to Present CE Mark Trial Results at OneMedForum 2014
10. Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014
11. PAREXEL International To Present At JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
(Date:1/14/2014)... As pet owners drew up their lists of New Year,s resolutions ... care of my furry companion." Nowadays there are pet salons, dog ... to take the little canine or feline darlings along wherever mommy ... some pricey toys at the pet store. But anyone who has ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... ... recent debate among weed scientists about how -- or even whether -- invasive saltcedar should ... answer critical questions about our natural ecosystems and carefully weigh the impact of our decisions. ... Lawrence, KS (PRWEB) August ...
... HANOVER, NH Despite their popularity in the science fiction ... the mysterious regions in space once thought to be absent ... issue of Physical Review Letters , the flagship journal ... way of creating a reproduction black hole in the laboratory ...
... , NANJING, China, Aug. 21 ... ("Simcere" or the "Company"), a leading manufacturer and supplier,of ... forty-two of its generic drugs have been included in ... Ministry of Health ("MOH") on,August 18, 2009. , ...
Cached Biology Technology:Invasive Saltcedar Triggers Lively Debate among Weed Scientists and Land Managers 2Invasive Saltcedar Triggers Lively Debate among Weed Scientists and Land Managers 3Dartmouth researchers propose new way to reproduce a black hole 2Forty-two of Simcere's Generic Drugs Enter China's Essential Drug List 2
(Date:4/17/2014)... in German . ... they also provide us with a continuous stream of information ... or sit still in a car the world glides ... retinas. Seemingly without effort, our brain calculates self-motion from this ... and a steady gaze during our own movements. Together with ...
(Date:4/17/2014)... in bone marrow need to produce hydrogen sulfide in ... to a new study from the Center for Craniofacial ... of USC. , Professor Songtao Shi, principal investigator on ... by the cells governs the flow of calcium ions. ... that results in osteogenesis, or the creation of new ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
Breaking Biology News(10 mins):How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... Oak Ridge National Laboratory have received seven R&D 100 Awards ... to as the "Academy Awards of Science," honor the 100 ... chosen by an expert panel of independent judges and the ... year,s R&D 100 award winners," Energy Secretary Steven Chu said. ...
... to increased awareness generated by the expanding local ... throughout the United States. The fresh market strawberry ... Floridastates with ideal weather conditions and long growing ... production operations succeed in other areas of the ...
... (CHICAGO) A neurological scientist at Rush University Medical ... of Health (NIH) to evaluate whether cinnamon, a common ... process of multiple sclerosis (MS). The two-year, $750,000 ... effects of cinnamon on the disease process in mice. ...
Cached Biology News:ORNL researchers win 7 R&D 100 awards 2ORNL researchers win 7 R&D 100 awards 3ORNL researchers win 7 R&D 100 awards 4ORNL researchers win 7 R&D 100 awards 5Early-season strawberry tested in high elevation conditions 2Potential impact of cinnamon on multiple sclerosis studied 2Potential impact of cinnamon on multiple sclerosis studied 3
... is Tecans fully automated solution for ... fast automation for cell-line maintenance, expansion, ... modular system built upon standard, industry ... liquid handling configuration capable of both ...
High-throughput DNA preparation and end sequencing of BAC libraries. 3730xl DNA sequencers. LIMS tracking utilizing Geospiza's Finch system. Full-length BAC sequencing also available. Our expertise h...
... ) The antibody is preadsorbed to remove any ... buffered aqueous glycerol solution A solution ... 2+ and Ca 2+ ), pH 7.3 ... (IgG, protease free) and 0.05% sodium azide A ...
High-throughput DNA sequencing of any library. Just give us your transformation mixture, and we'll do the rest. ABI 3730xl's yield the longest read lengths available. LIMS tracking utilizing Geospiza...
Biology Products: